Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01090141 · ClinicalTrials.gov registry record · Phase 4
Drug Concentration Analysis of Micafungin in Overweight, Obese, and Extremely Obese Volunteers
A Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 36
- Enrollment target
NCT01090141 is a Phase 4 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 36 participants.
The verdict
NCT01090141, a Phase 4 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the drug concentration of Micafungin amongst healthy volunteers having different weight groups.
Interventions
- DRUG Micafungin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2009-11 |
| Est. Completion | 2010-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01090141
The ClinicalTrials.gov registry entry for NCT01090141 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Micafungin is the first listed.
NCT01090141 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01090141 about?
NCT01090141 is a clinical study titled "Drug Concentration Analysis of Micafungin in Overweight, Obese, and Extremely Obese Volunteers". The purpose of this study is to assess the drug concentration of Micafungin amongst healthy volunteers having different weight groups.
What is the current status of trial NCT01090141?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2009-11. Estimated completion is 2010-06.
What interventions are being tested in trial NCT01090141?
The interventions under investigation include: Micafungin (DRUG).
Who is sponsoring clinical trial NCT01090141?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.